Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this drugmaker have returned +14.7% over the past month versus the Zacks S&P 500 composite's +5.1% change. The Zacks Large Cap Pharmaceuticals industry, to which Lilly belongs, has gained 4.3% over this period. Now the key question is: Where could the stock be headed in the near term?Although media reports ...